| Study Group (Bemiparin +) | Control Group (Bemiparin −) |
MTHFR C677T Heterozygote Mutation | 46 (71.87%) | 36 (64.28%) |
MTHFR C677T Homozygote Mutation | 18 (28.12%) | 20 (35.71%) |
Total | 64 | 56 |